학술논문

Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency

Document Type

Article

Author

Rigolin, G.M.; Tognolo, L.; Ballardini, M.P.; Urso, A.; Sessa, M.; Gambara, S.; Cura, F.; Fortini, M.; Cuneo, A.; Olimpieri, P.P.; Summa, V.; Celant, S.; Russo, P.; Scarfò, L.; Ghia, P.

Source

In: Blood Cancer Journal. (Blood Cancer Journal, December 2023, 13(1))

Subject

Language

English

ISSN

20445385

Online Access

Full Text (ProQuest Central) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송